Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis.

Shobana Anpalakhan,Prerana Huddar,Roya Behrouzi,Alessio Signori,Judith Cave,Charles Comins,Alessio Cortellini,Alfredo Addeo,Carles Escriu,Hayley McKenzie,Gloria Barone,Lisa Murray,David J Pinato,Christian Ottensmeier,Sara Campos,Sethupathi Muthuramalingam,Samuel Chan,Fabio Gomes,Giuseppe L Banna

Frontiers in oncology（2023）

引用 0|浏览10

暂无评分

摘要

These results confirm survival outcome benefits in patients with irAEs and suggest a higher likelihood of Grade 1-2 irAEs in patients with lower NLR or SII values or according to the NHS-Lung score.

查看译文

关键词

chemoimmunotherapy,lung cancer,adverse events,immunotherapy-related,real-world,non-small,sub-analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要